Man Group PLC Biogen Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Biogen Inc. stock. As of the latest transaction made, Man Group PLC holds 856,835 shares of BIIB stock, worth $135 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

856,835

Previous 57,595 1387.69%

Holding current value

$135 Million

Previous $13.4 Million 1144.01%

% of portfolio

0.46%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $151 Million - $189 Million	799,240 Added 1387.69%	856,835 $166 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $181,756 - $225,830	954 Added 1.68%	57,595 $13.4 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $2.83 Million - $3.58 Million	-13,367 Reduced 19.09%	56,641 $12.2 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $8.49 Million - $10.2 Million	-38,160 Reduced 35.28%	70,008 $18.1 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $15.9 Million - $17.9 Million	-62,643 Reduced 36.67%	108,168 $27.8 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $19.4 Million - $22.4 Million	-70,367 Reduced 29.18%	170,811 $48.7 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $117 Million - $133 Million	-454,106 Reduced 65.31%	241,178 $67.1 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $6.59 Million - $8.01 Million	26,106 Added 3.9%	695,284 $193 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $24.1 Million - $33.3 Million	-123,977 Reduced 15.63%	669,178 $179 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $5.19 Million - $6.17 Million	-27,656 Reduced 3.37%	793,155 $162 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $118 Million - $148 Million	607,363 Added 284.55%	820,811 $173 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $8.29 Million - $10.7 Million	37,009 Added 20.98%	213,448 $51.2 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $39.6 Million - $51.7 Million	140,104 Added 385.59%	176,439 $49.9 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $2.72 Million - $4.35 Million	10,492 Added 40.6%	36,335 $12.6 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $24.9 Million - $29.2 Million	-102,645 Reduced 79.89%	25,843 $7.23 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $50.4 Million - $75.9 Million	-213,438 Reduced 62.42%	128,488 $31.5 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $39.9 Million - $46.1 Million	-150,644 Reduced 30.58%	341,926 $97 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $19.5 Million - $25.8 Million	-75,322 Reduced 13.26%	492,570 $132 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $38 Million - $48.3 Million	-141,524 Reduced 19.95%	567,892 $180 Million
Q4 2019 Feb 18, 2020	BUY	$220.06 - $304.07 $3.21 Million - $4.43 Million	14,574 Added 2.1%	709,416 $211 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $48.3 Million - $54.2 Million	222,250 Added 47.03%	694,842 $162 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $35.4 Million - $39 Million	161,432 Added 51.88%	472,592 $111 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $24.9 Million - $38.9 Million	-114,893 Reduced 26.97%	311,160 $73.6 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $20.6 Million - $26.1 Million	73,861 Added 20.97%	426,053 $128 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $94,510 - $123,593	-322 Reduced 0.09%	352,192 $124 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $19.2 Million - $22.8 Million	74,385 Added 26.74%	352,514 $102 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $72.3 Million - $102 Million	278,129 New	278,129 $76.2 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account